More Articles Back to Article

CDC Data Show Pfizer-BioNTech’s COVID-19 Vaccine 93% Effective Against Hospitalization For Youths Aged 12 To 18

The New York Times (10/19, Mueller) reports that according to CDC data published in its Morbidity and Mortality Weekly Report, Pfizer-BioNTech’s COVID-19 “vaccine was 93 percent effective against hospitalization with Covid-19 among 12- to 18-year-olds.” The CDC “studied young people who were hospitalized at 19 pediatric hospitals across 16 states from June through September, as the Delta variant spread across the country and exacted a devastating toll in less-vaccinated states in the South and West.” The Times adds, “Nearly three-quarters of the Covid patients in the study had at least one underlying health condition, including obesity, diabetes, asthma or respiratory disorders, putting them at higher risk of severe illness.”
      Reuters (10/19, Mishra) reports the data “showed that among the 179 patients who were hospitalized for COVID-19, 97% were unvaccinated,” and “of the roughly 16% of patients hospitalized with severe enough COVID-19 to require life support, none were vaccinated.”
      On its website, CNN (10/19, McPhillips) reports, “Vaccine effectiveness differed only slightly within that age group, with 91% effectiveness for children age 12 to 15 and 94% effectiveness for those age 16 to 18.”
      The Hill (10/19, Coleman) also reports on the research.

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!